These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
326 related articles for article (PubMed ID: 34245428)
1. Genome-wide scanning for CHD1L gene in papillary thyroid carcinoma complicated with type 2 diabetes mellitus. Kang YY; Li JJ; Sun JX; Wei JX; Ding C; Shi CL; Wu G; Li K; Ma YF; Sun Y; Qiao H Clin Transl Oncol; 2021 Dec; 23(12):2536-2547. PubMed ID: 34245428 [TBL] [Abstract][Full Text] [Related]
2. BCL2 and hsa-miR-181a-5p are potential biomarkers associated with papillary thyroid cancer based on bioinformatics analysis. Zhang C; Bo C; Guo L; Yu P; Miao S; Gu X World J Surg Oncol; 2019 Dec; 17(1):221. PubMed ID: 31842912 [TBL] [Abstract][Full Text] [Related]
3. Identification of biomarkers associated with cervical lymph node metastasis in papillary thyroid carcinoma: Evidence from an integrated bioinformatic analysis. Zhang Z; Zhao S; Wang K; Shang M; Chen Z; Yang H; Chen Y; Chen B Clin Hemorheol Microcirc; 2021; 78(2):117-126. PubMed ID: 33554894 [TBL] [Abstract][Full Text] [Related]
4. OGDHL closely associates with tumor microenvironment and can serve as a prognostic biomarker for papillary thyroid cancer. Mao M; Huang RZ; Zheng J; Liang HQ; Huang WH; Liu J; Li JH Cancer Med; 2021 Jan; 10(2):728-736. PubMed ID: 33405394 [TBL] [Abstract][Full Text] [Related]
5. TREM2 Is a Prognostic Biomarker and Correlated with an Immunosuppressive Microenvironment in Thyroid Cancer. Wang J; Li Z Dis Markers; 2022; 2022():1807386. PubMed ID: 36438899 [TBL] [Abstract][Full Text] [Related]
6. Tumor Mutation Burden Predicts Relapse in Papillary Thyroid Carcinoma With Changes in Genes and Immune Microenvironment. Guo M; Chen Z; Li Y; Li S; Shen F; Gan X; Feng J; Cai W; Liu Q; Xu B Front Endocrinol (Lausanne); 2021; 12():674616. PubMed ID: 34248843 [TBL] [Abstract][Full Text] [Related]
7. Identification of ferroptosis genes in immune infiltration and prognosis in thyroid papillary carcinoma using network analysis. Lin R; Fogarty CE; Ma B; Li H; Ni G; Liu X; Yuan J; Wang T BMC Genomics; 2021 Jul; 22(1):576. PubMed ID: 34315405 [TBL] [Abstract][Full Text] [Related]
8. Biomarkers related to m6A and succinic acid metabolism in papillary thyroid carcinoma. Li M; Fu X; Zhou T; Han H BMC Med Genomics; 2024 Aug; 17(1):199. PubMed ID: 39113023 [TBL] [Abstract][Full Text] [Related]
9. Identification of potential biomarkers for papillary thyroid carcinoma by comprehensive bioinformatics analysis. Liao M; Wang Z; Yao J; Xing H; Hao Y; Qiu B Mol Cell Biochem; 2023 Sep; 478(9):2111-2123. PubMed ID: 36635603 [TBL] [Abstract][Full Text] [Related]
10. CXCL10 is a potential biomarker and associated with immune infiltration in human papillary thyroid cancer. Qin XJ; Lin X; Xue G; Fan HL; Wang HY; Wu JF; Pei D Biosci Rep; 2021 Jan; 41(1):. PubMed ID: 33345267 [TBL] [Abstract][Full Text] [Related]
11. Integrated analysis of tumor microenvironment features to establish a diagnostic model for papillary thyroid cancer using bulk and single-cell RNA sequencing technology. Wang Y; Song W; Li Y; Liu Z; Zhao K; Jia L; Wang X; Jiang R; Tian Y; He X J Cancer Res Clin Oncol; 2023 Dec; 149(18):16837-16850. PubMed ID: 37733241 [TBL] [Abstract][Full Text] [Related]
12. Identification of lipid metabolism-related genes as prognostic indicators in papillary thyroid cancer. Wen S; Luo Y; Wu W; Zhang T; Yang Y; Ji Q; Wu Y; Shi R; Ma B; Xu M; Qu N Acta Biochim Biophys Sin (Shanghai); 2021 Dec; 53(12):1579-1589. PubMed ID: 34693452 [TBL] [Abstract][Full Text] [Related]
13. CXCL5 expression is associated with active signals of macrophages in the microenvironment of papillary thyroid carcinoma. Le TN; Le MK; Dang MX; Kondo T Pathol Res Pract; 2024 Sep; 261():155474. PubMed ID: 39067172 [TBL] [Abstract][Full Text] [Related]
14. GADD45B Transcript Is a Prognostic Marker in Papillary Thyroid Carcinoma Patients Treated With Total Thyroidectomy and Radioiodine Therapy. Barros-Filho MC; de Mello JBH; Marchi FA; Pinto CAL; da Silva IC; Damasceno PKF; Soares MBP; Kowalski LP; Rogatto SR Front Endocrinol (Lausanne); 2020; 11():269. PubMed ID: 32425887 [TBL] [Abstract][Full Text] [Related]
15. Single-cell and bulk RNA sequencing reveal heterogeneity and diagnostic markers in papillary thyroid carcinoma lymph-node metastasis. Lu DN; Zhang WC; Lin YZ; Jiang HY; He R; Li SL; Zhang YN; Shao CY; Zheng CM; Xu JJ; Ge MH J Endocrinol Invest; 2024 Jun; 47(6):1513-1530. PubMed ID: 38146045 [TBL] [Abstract][Full Text] [Related]
16. Role of differentially expressed genes and long non-coding RNAs in papillary thyroid carcinoma diagnosis, progression, and prognosis. Cai WY; Chen X; Chen LP; Li Q; Du XJ; Zhou YY J Cell Biochem; 2018 Nov; 119(10):8249-8259. PubMed ID: 29968931 [TBL] [Abstract][Full Text] [Related]
17. Identification of Biomarkers Based on Differentially Expressed Genes in Papillary Thyroid Carcinoma. Han J; Chen M; Wang Y; Gong B; Zhuang T; Liang L; Qiao H Sci Rep; 2018 Jul; 8(1):9912. PubMed ID: 29967488 [TBL] [Abstract][Full Text] [Related]
18. Special role of JUN in papillary thyroid carcinoma based on bioinformatics analysis. Chen W; Liu Q; Lv Y; Xu D; Chen W; Yu J World J Surg Oncol; 2017 Jul; 15(1):119. PubMed ID: 28673327 [TBL] [Abstract][Full Text] [Related]
19. Low expression of Yang L; Zhang X; Zhang J; Liu Y; Ji T; Mou J; Fang X; Wang S; Chen J Future Oncol; 2022 Jan; 18(3):333-348. PubMed ID: 34756116 [TBL] [Abstract][Full Text] [Related]
20. Identification of differentiated functional modules in papillary thyroid carcinoma by analyzing differential networks. Yang C; Wang Y J Cancer Res Ther; 2018 Dec; 14(Supplement):S969-S974. PubMed ID: 30539831 [TBL] [Abstract][Full Text] [Related] [Next] [New Search]